Centene (CNC) Financials: History & Chart

Centene Corp. (CNC)CNCCentene Corp.

About Centene Corp.

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

St. Louis, MO

61,100 employees

www.centene.com

Healthcare / Medical - Healthcare Plans

Sector: Healthcare
Industry: Medical - Healthcare Plans
CEO: Sarah London

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	198.10B	49.94B	49.73B	49.69B	48.74B	46.62B	40.80B	42.02B	39.84B
Cost of Goods Sold	168.53B	39.01B	42.18B	41.55B	45.80B	41.42B	37.09B	37.99B	35.41B
Gross Profit	29.57B	10.94B	7.55B	8.14B	2.95B	5.20B	3.72B	4.04B	4.43B
Gross Profit Margin	14.9%	21.9%	15.2%	16.4%	6.0%	11.2%	9.1%	9.6%	11.1%
Total Operating Expenses	36.86B	9.08B	9.29B	15.09B	3.40B	3.67B	3.54B	3.37B	3.20B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	13.31B	3.40B	3.73B	3.15B	3.04B	3.35B	3.23B	3.06B	2.89B
Operating Income (EBIT)	-7.29B	1.86B	-1.74B	-6.95B	-458.00M	1.53B	175.00M	665.00M	1.23B
Operating Margin	-3.7%	3.7%	-3.5%	-14.0%	-0.9%	3.3%	0.4%	1.6%	3.1%
Income Before Tax (EBT)	-6.37B	2.10B	-1.54B	-6.67B	-257.00M	1.75B	347.00M	921.00M	1.52B
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	672.00M	164.00M	168.00M	170.00M	170.00M	170.00M	172.00M	176.00M	176.00M
Other Income/Expense	916.41M	238.00M	197.41M	280.00M	201.00M	212.00M	172.00M	256.00M	287.00M
Net Income	-6.44B	1.54B	-1.10B	-6.63B	-253.00M	1.31B	283.00M	713.00M	1.15B
Income Tax Expense	77.04M	560.00M	-442.96M	-42.00M	2.00M	432.00M	67.00M	211.00M	370.00M
Net Profit Margin	-3.3%	3.1%	-2.2%	-13.3%	-0.5%	2.8%	0.7%	1.7%	2.9%
EBITDA	-6.03B	2.16B	-1.41B	-6.64B	-143.00M	1.85B	489.00M	978.00M	1.53B
EBITDA Margin	-3.0%	4.3%	-2.8%	-13.4%	-0.3%	4.0%	1.2%	2.3%	3.9%
Depreciation & Amortization	1.26B	300.00M	329.00M	316.00M	315.00M	315.00M	314.00M	313.00M	306.00M
EPS Basic	-13.12	3.13	-2.24	-13.50	-0.51	2.64	0.57	1.37	2.16
EPS Diluted	-13.14	3.11	-2.24	-13.50	-0.51	2.63	0.56	1.36	2.16
Shares Outstanding	492.07M	492.07M	491.07M	491.14M	493.55M	496.21M	500.42M	521.97M	529.60M
Diluted Shares Outstanding	495.59M	495.59M	491.07M	491.14M	493.55M	498.18M	501.98M	523.54M	530.75M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	194.78B	163.07B	154.00B	144.55B	125.98B	111.11B	74.64B	60.12B
Cost of Goods Sold	170.94B	146.24B	136.68B	127.89B	111.78B	95.90B	65.80B	51.70B
Gross Profit	23.83B	16.83B	17.32B	16.66B	14.20B	15.22B	8.84B	8.42B
Gross Profit Margin	12.2%	10.3%	11.2%	11.5%	11.3%	13.7%	11.8%	14.0%
Total Operating Expenses	31.45B	13.65B	14.38B	15.34B	12.41B	12.13B	7.06B	6.96B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	13.26B	12.40B	12.56B	11.59B	9.60B	11.34B	6.53B	6.75B
Operating Income (EBIT)	-7.62B	3.17B	2.93B	1.32B	1.78B	3.08B	1.78B	1.46B
Operating Margin	-3.9%	1.9%	1.9%	0.9%	1.4%	2.8%	2.4%	2.4%
Income Before Tax (EBT)	-6.73B	4.26B	3.60B	1.96B	1.81B	2.77B	1.78B	1.37B
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	678.00M	702.00M	725.00M	665.00M	665.00M	728.00M	412.00M	343.00M
Other Income/Expense	890.41M	1.08B	668.00M	644.00M	29.00M	-309.00M	1.00M	-90.00M
Net Income	-6.67B	3.31B	2.70B	1.20B	1.35B	1.81B	1.32B	900.00M
Income Tax Expense	-50.96M	963.00M	899.00M	760.00M	477.00M	979.00M	473.00M	474.00M
Net Profit Margin	-3.4%	2.0%	1.8%	0.8%	1.1%	1.6%	1.8%	1.5%
EBITDA	-6.34B	4.42B	4.22B	2.75B	3.12B	4.34B	2.42B	1.95B
EBITDA Margin	-3.3%	2.7%	2.7%	1.9%	2.5%	3.9%	3.2%	3.2%
Depreciation & Amortization	1.27B	1.24B	1.29B	1.43B	1.33B	1.26B	643.00M	495.00M
EPS Basic	-13.61	6.33	4.97	2.09	2.31	3.17	3.19	2.31
EPS Diluted	-13.62	6.31	4.95	2.07	2.28	3.12	3.14	2.26
Shares Outstanding	491.07M	521.79M	543.32M	575.19M	582.83M	570.72M	413.49M	390.25M
Diluted Shares Outstanding	491.07M	523.74M	545.70M	582.04M	590.52M	579.13M	420.41M	398.51M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.